Brief: Integral Diagnostics Posts Groupwide Organic Revenue Growth Of 9.0% YTD October 2023
Nov 29 (Reuters) - Integral Diagnostics Ltd IDX.AX :
* GROUPWIDE ORGANIC REVENUE GROWTH OF 9.0% YTD OCTOBER 2023
Source text for Eikon: ID:nASX9Xhy1B
Further company coverage: IDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Integral Diagnostics
See all newsBrief: Integral Diagnostics Announces Preliminary FY26 Results And Appointment Of New CFO
Brief: Integral Diagnostics Responds To Media Reporting In WA
Australia's Integral Diagnostics loses most in 1-1/2 years, denies allegations on inappropriate billing
Jardine's $2.4 bln radiology pivot scans well
Jardine's $2.4 bln radiology pivot scans well